These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35097114)

  • 1. Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer.
    Wang J; Chen P; Su M; Zhong G; Zhang S; Gou D
    Biomed Res Int; 2022; 2022():2698190. PubMed ID: 35097114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma.
    Li Y; Jiang W; Li T; Li M; Li X; Zhang Z; Zhang S; Liu Y; Zhao W; Gu Y; Qi L; Ao L; Guo Z
    J Transl Med; 2020 Jan; 18(1):25. PubMed ID: 31937321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
    Li M; Gao X; Wang X
    Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
    Tian Y; Xu J; Chu Q; Duan J; Zhang J; Bai H; Yang Z; Fang W; Cai L; Wan R; Fei K; He J; Gao S; Zhang L; Wang Z; Wang J
    BMC Med; 2020 Aug; 18(1):232. PubMed ID: 32843031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker.
    He B; Dong D; She Y; Zhou C; Fang M; Zhu Y; Zhang H; Huang Z; Jiang T; Tian J; Chen C
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32636239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature.
    Wang X; Kong C; Xu W; Yang S; Shi D; Zhang J; Du M; Wang S; Bai Y; Zhang T; Chen Z; Ma Z; Wang J; Dong G; Sun M; Yin R; Chen F
    Thorac Cancer; 2019 Oct; 10(10):1904-1912. PubMed ID: 31414580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An miRNA signature associated with tumor mutation burden in endometrial cancer.
    Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer.
    Lu N; Liu J; Ji C; Wang Y; Wu Z; Yuan S; Xing Y; Diao F
    Bioengineered; 2021 Dec; 12(1):3603-3620. PubMed ID: 34252354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multi-classification prediction model of lung cancer tumor mutation burden based on residual network].
    Meng X; Yu C; Yang X; Yang Z; Liu D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Oct; 40(5):867-875. PubMed ID: 37879915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an interpretable radiomic signature for preoperative estimation of tumor mutational burden in lung adenocarcinoma.
    Zhang Y; Yang Y; Ma Y; Liu Y; Ye Z
    Front Genet; 2024; 15():1367434. PubMed ID: 38660677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non-Small-Cell Lung Cancer.
    Zhang N; Wu J; Yu J; Zhu H; Yang M; Li R
    Clin Lung Cancer; 2020 May; 21(3):e151-e163. PubMed ID: 31734072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
    Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
    Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning.
    Niu Y; Wang L; Zhang X; Han Y; Yang C; Bai H; Huang K; Ren C; Tian G; Yin S; Zhao Y; Wang Y; Shi X; Zhang M
    Front Oncol; 2022; 12():927426. PubMed ID: 35756617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
    Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
    J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas.
    Wang C; Liang H; Lin C; Li F; Xie G; Qiao S; Shi X; Deng J; Zhao X; Wu K; Zhang X
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
    Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
    Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.